Treatment of patients with ibandronate and correlation with serum carboxy-terminal telopeptide of type I collagen levels

6734 Background: Ibandronate (IB) is found to reduce, significantly, the occurrence of osteolytic bone lesions in a murine model of myeloma bone disease. The carboxy-terminal telopeptide of type I ...